Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Depressive Disorder, Treatment-Resistant

fluorodeoxyglucose f18 has been researched along with Depressive Disorder, Treatment-Resistant in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (87.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Baeken, C; De Raedt, R; Wu, GR1
Baeken, C; De Raedt, R; Van Schuerbeek, P; Wu, GR1
Brutsche, N; Carlson, PJ; Diazgranados, N; Drevets, WC; Herscovitch, P; Ibrahim, L; Luckenbaugh, DA; Manji, HK; Nugent, AC; Zarate, CA1
Ameli, R; Lally, N; Luckenbaugh, DA; Nugent, AC; Roiser, JP; Zarate, CA1
Bewernick, BH; Hurlemann, R; Kayser, S; Matusch, A; Schlaepfer, TE; Soehle, M1
Baeken, C; Wu, GR1
Chen, MH; Hong, CJ; Li, CT; Lin, WC; Liu, RS; Su, TP; Tu, PC; Yang, BH1
Bucholz, RD; Chibnall, JT; Christensen, JJ; Conway, CR; Gangwani, S; Giuffra, LA; Hershey, T; Mintun, MA; Price, JL; Sheline, YI1

Trials

4 trial(s) available for fluorodeoxyglucose f18 and Depressive Disorder, Treatment-Resistant

ArticleYear
Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.
    Biological psychiatry, 2013, Jun-15, Volume: 73, Issue:12

    Topics: Adult; Antidepressive Agents; Brain; Brain Mapping; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Ketamine; Magnetic Resonance Imaging; Male; Middle Aged; Oxygen; Positron-Emission Tomography

2013
Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.
    Translational psychiatry, 2014, Oct-14, Volume: 4

    Topics: Adolescent; Adult; Aged; Anhedonia; Bipolar Disorder; Brain; Cross-Over Studies; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Humans; Ketamine; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome; Young Adult

2014
Magnetic seizure therapy in treatment-resistant depression: clinical, neuropsychological and metabolic effects.
    Psychological medicine, 2015, Volume: 45, Issue:5

    Topics: Adult; Anxiety; Brain; Convulsive Therapy; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Magnetic Field Therapy; Male; Middle Aged; Positron-Emission Tomography; Quality of Life; Radiopharmaceuticals; Recurrence; Treatment Outcome

2015
The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.
    Human brain mapping, 2016, Volume: 37, Issue:3

    Topics: Adult; Amygdala; Antidepressive Agents; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Fluorodeoxyglucose F18; Glutamic Acid; Humans; Ketamine; Linear Models; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Psychiatric Status Rating Scales; Radiopharmaceuticals

2016

Other Studies

4 other study(ies) available for fluorodeoxyglucose f18 and Depressive Disorder, Treatment-Resistant

ArticleYear
Dorsomedial frontal cortical metabolic differences of comorbid generalized anxiety disorder in refractory major depression: A [
    Journal of affective disorders, 2018, Volume: 227

    Topics: Adult; Anxiety Disorders; Comorbidity; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals

2018
Opposite subgenual cingulate cortical functional connectivity and metabolic activity patterns in refractory melancholic major depression.
    Brain imaging and behavior, 2020, Volume: 14, Issue:2

    Topics: Adult; Brain; Brain Mapping; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prefrontal Cortex; Temporal Lobe; Transcranial Magnetic Stimulation

2020
Longer depressive episode duration negatively influences HF-rTMS treatment response: a cerebellar metabolic deficiency?
    Brain imaging and behavior, 2017, Volume: 11, Issue:1

    Topics: Adult; Brain; Brain Mapping; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Transcranial Magnetic Stimulation; Treatment Outcome

2017
Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response?
    Journal of affective disorders, 2012, Volume: 139, Issue:3

    Topics: Adult; Cerebral Cortex; Depressive Disorder, Treatment-Resistant; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Vagus Nerve Stimulation

2012